Mutations of Chromatin Structure Regulating Genes in Human Malignancies
- PMID: 26796307
- PMCID: PMC5403969
- DOI: 10.2174/1389203717666160122120008
Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Abstract
Chromatin structure regulating processes mediated by the adenosine triphosphate (ATP) - dependent chromatin remodeling complex and the covalent histone-modifying complexes are critical to gene transcriptional control and normal cellular processes, including cell stemness, differentiation, and proliferation. Gene mutations, structural abnormalities, and epigenetic modifications that lead to aberrant expression of chromatin structure regulating members have been observed in most of human malignancies. Advances in next-generation sequencing (NGS) technologies in recent years have allowed in-depth study of somatic mutations in human cancer samples. The Cancer Genome Atlas (TCGA) is the largest effort to date to characterize cancer genome using NGS technology. In this review, we summarize somatic mutations of chromatin-structure regulating genes from TCGA publications and other cancer genome studies, providing an overview of genomic alterations of chromatin regulating genes in human malignancies.
Similar articles
-
The Roles of Chromatin Remodeling Proteins in Cancer.Curr Protein Pept Sci. 2016;17(5):446-54. doi: 10.2174/1389203717666160122120713. Curr Protein Pept Sci. 2016. PMID: 26796304 Review.
-
Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer.Curr Protein Pept Sci. 2016;17(5):455-62. doi: 10.2174/1389203717666160122121340. Curr Protein Pept Sci. 2016. PMID: 26796303 Review.
-
An Overview of Chromatin-Regulating Proteins in Cells.Curr Protein Pept Sci. 2016;17(5):401-10. doi: 10.2174/1389203717666160122120310. Curr Protein Pept Sci. 2016. PMID: 26796306 Free PMC article. Review.
-
Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.Jpn J Clin Oncol. 2013 Sep;43(9):849-55. doi: 10.1093/jjco/hyt101. Epub 2013 Jul 30. Jpn J Clin Oncol. 2013. PMID: 23904343
-
Targeting histone modifications--epigenetics in cancer.Curr Opin Cell Biol. 2013 Apr;25(2):184-9. doi: 10.1016/j.ceb.2013.01.001. Epub 2013 Jan 21. Curr Opin Cell Biol. 2013. PMID: 23347561 Review.
Cited by
-
Pan-cancer discovery of somatic mutations from RNA sequencing data.Commun Biol. 2024 May 23;7(1):619. doi: 10.1038/s42003-024-06326-y. Commun Biol. 2024. PMID: 38783092 Free PMC article.
-
Multilevel view on chromatin architecture alterations in cancer.Front Genet. 2022 Nov 18;13:1059617. doi: 10.3389/fgene.2022.1059617. eCollection 2022. Front Genet. 2022. PMID: 36468037 Free PMC article. Review.
-
The therapeutic potential of targeting the CHD protein family in cancer.Pharmacol Ther. 2024 Apr;256:108610. doi: 10.1016/j.pharmthera.2024.108610. Epub 2024 Feb 15. Pharmacol Ther. 2024. PMID: 38367868 Review.
-
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.Cancers (Basel). 2024 Jan 5;16(2):246. doi: 10.3390/cancers16020246. Cancers (Basel). 2024. PMID: 38254738 Free PMC article. Review.
-
The non-specific lethal (NSL) complex at the crossroads of transcriptional control and cellular homeostasis.EMBO Rep. 2019 Jul;20(7):e47630. doi: 10.15252/embr.201847630. Epub 2019 Jun 3. EMBO Rep. 2019. PMID: 31267707 Free PMC article. Review.
References
-
- Clapier C.R., Cairns B.R. The biology of chromatin remodeling complexes. Annu. Rev. Biochem. 2009;78:273–304. - PubMed
-
- Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., Antipin Y., Reva B., Goldberg A.P., Sander C., Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. - PMC - PubMed
-
- Wilson B.G., Roberts C.W. SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer. 2011;11(7):481–492. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources